Table 2.
Coagulation Variables Between the Six Fibrinolysis Phenotypes
| t-TEG r-TEG |
nHS SD |
nHS PY |
nHS HY |
HS SD |
HS PY |
HS HY |
P Overall |
|---|---|---|---|---|---|---|---|
| ACT | 121 (113–128) | 121 (113–128) | 128 (115–136) | 121 (113–152) | 121 (113–132) | 132 (119–162) | <0.016 |
| Angle | 72 (65–75) | 73 (69–76) | 71 (66–76) | 68 (59–71) | 70 (64–73) | 63 (52–70) | <0.001 |
| MA | 64 (58–66) | 65 (62–68) | 61 (58–66) | 55 (47–62) | 60 (55–64) | 51 (40–60) | <0.001 |
| LY30 | 0.4 (0–0.6) | 1.8 (1.4–2.3) | 3.8 (3.4–5.3) | 0.3 (0.1–0.6) | 1.7 (1.2–2.2) | 9.2 (4.0–51) | <0.001 |
| INR | 1.1 (1.01–1.1) | 1.1 (1.0–1.1) | 1.1 (1.1–1.2) | 1.3 (1.2–1.8) | 1.2 (1.1–1.4) | 1.5 (1.2–2.2) | <0.001 |
| Plt Count | 235 (191–293) | 274 (227–322) | 272 (221–321) | 192 (100–246) | 238 (207–282) | 170 (124–256) | <0.001 |
| ADP Plt MA | 36 (13–54) | 45 (30–57) | 45 (30–57) | 21 (14–34) | 29 (10–36) | 18 (4–41) | =0.005 |
| Coag Score | 1 (1–2) | 1 (1–1) | 1 (1–1) | 2 (1–3) | 1 (1–3) | 3 (1–4) | <0.001 |
| MT | 8% | 1% | 3% | 16% | 16% | 47% | <0.001 |
nHS= non hypersensitive ; HS= t-PA hypersensitive; SD = shutdown; PY = physiologic; HY = hyperfibrinolysis.